Mrs Lature Elease Hicks, NP-C | |
1100 N Woolsey Ave, Fayetteville, AR 72703-1847 | |
(479) 444-7548 | |
Not Available |
Full Name | Mrs Lature Elease Hicks |
---|---|
Gender | Female |
Speciality | Nurse Practitioner |
Experience | 19 Years |
Location | 1100 N Woolsey Ave, Fayetteville, Arkansas |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043303019 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
363LF0000X | Nurse Practitioner - Family | A02945 (Arkansas) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Wellstar Kennestone Hospital | Marietta, GA | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
Wellstar Medical Group, Llc | 6709065402 | 1839 |
News Archive
Genesis Biopharma, Inc., a biotechnology company developing targeted cancer therapies, today announced an expanded clinical focus to include an autologous cell therapy product candidate, Contego™, for the treatment of Stage IV metastatic melanoma.
More than 2,000 people have died of cholera in Haiti since late October, Haitian officials said on Monday, the Associated Press/Washington Post reports (12/6). According to Haitian health ministry figures, a total of "2,013 people have died from the water-borne bacterial infection and 88,789 cases have been recorded," Agence France-Presse writes (12/6).
LSP (Life Sciences Partners), the specialist healthcare investment firm, has announced today a strategic collaboration with Bristol-Myers Squibb Company in which the companies will work closely together in identifying European breakthrough technologies and products in immuno-oncology and other areas of unmet medical need.
Politico Pro examines how the marketplaces operated by states compare to the federally run operation. Other outlets look at some of the individual issues in states.
Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS) today announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation to Restanza(TM) (cethromycin), its novel, once daily oral antibiotic, for the prophylactic treatment of plague and tularemia. Both tularemia and plague are classified by the Centers for Disease Control as Category A Bioterrorism Agents, which is the highest priority classification.
› Verified 5 days ago
Entity Name | Wellstar Medical Group, Llc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1558664003 PECOS PAC ID: 6709065402 Enrollment ID: O20110127000374 |
News Archive
Genesis Biopharma, Inc., a biotechnology company developing targeted cancer therapies, today announced an expanded clinical focus to include an autologous cell therapy product candidate, Contego™, for the treatment of Stage IV metastatic melanoma.
More than 2,000 people have died of cholera in Haiti since late October, Haitian officials said on Monday, the Associated Press/Washington Post reports (12/6). According to Haitian health ministry figures, a total of "2,013 people have died from the water-borne bacterial infection and 88,789 cases have been recorded," Agence France-Presse writes (12/6).
LSP (Life Sciences Partners), the specialist healthcare investment firm, has announced today a strategic collaboration with Bristol-Myers Squibb Company in which the companies will work closely together in identifying European breakthrough technologies and products in immuno-oncology and other areas of unmet medical need.
Politico Pro examines how the marketplaces operated by states compare to the federally run operation. Other outlets look at some of the individual issues in states.
Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS) today announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation to Restanza(TM) (cethromycin), its novel, once daily oral antibiotic, for the prophylactic treatment of plague and tularemia. Both tularemia and plague are classified by the Centers for Disease Control as Category A Bioterrorism Agents, which is the highest priority classification.
› Verified 5 days ago
Entity Name | Medcura Health, Inc |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1417011487 PECOS PAC ID: 2961443643 Enrollment ID: O20120509000245 |
News Archive
Genesis Biopharma, Inc., a biotechnology company developing targeted cancer therapies, today announced an expanded clinical focus to include an autologous cell therapy product candidate, Contego™, for the treatment of Stage IV metastatic melanoma.
More than 2,000 people have died of cholera in Haiti since late October, Haitian officials said on Monday, the Associated Press/Washington Post reports (12/6). According to Haitian health ministry figures, a total of "2,013 people have died from the water-borne bacterial infection and 88,789 cases have been recorded," Agence France-Presse writes (12/6).
LSP (Life Sciences Partners), the specialist healthcare investment firm, has announced today a strategic collaboration with Bristol-Myers Squibb Company in which the companies will work closely together in identifying European breakthrough technologies and products in immuno-oncology and other areas of unmet medical need.
Politico Pro examines how the marketplaces operated by states compare to the federally run operation. Other outlets look at some of the individual issues in states.
Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS) today announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation to Restanza(TM) (cethromycin), its novel, once daily oral antibiotic, for the prophylactic treatment of plague and tularemia. Both tularemia and plague are classified by the Centers for Disease Control as Category A Bioterrorism Agents, which is the highest priority classification.
› Verified 5 days ago
Mailing Address | Practice Location Address |
---|---|
Mrs Lature Elease Hicks, NP-C 1100 N Woolsey Ave, Fayetteville, AR 72703-1847 Ph: (479) 444-7548 | Mrs Lature Elease Hicks, NP-C 1100 N Woolsey Ave, Fayetteville, AR 72703-1847 Ph: (479) 444-7548 |
News Archive
Genesis Biopharma, Inc., a biotechnology company developing targeted cancer therapies, today announced an expanded clinical focus to include an autologous cell therapy product candidate, Contego™, for the treatment of Stage IV metastatic melanoma.
More than 2,000 people have died of cholera in Haiti since late October, Haitian officials said on Monday, the Associated Press/Washington Post reports (12/6). According to Haitian health ministry figures, a total of "2,013 people have died from the water-borne bacterial infection and 88,789 cases have been recorded," Agence France-Presse writes (12/6).
LSP (Life Sciences Partners), the specialist healthcare investment firm, has announced today a strategic collaboration with Bristol-Myers Squibb Company in which the companies will work closely together in identifying European breakthrough technologies and products in immuno-oncology and other areas of unmet medical need.
Politico Pro examines how the marketplaces operated by states compare to the federally run operation. Other outlets look at some of the individual issues in states.
Advanced Life Sciences Holdings, Inc. (OTC Bulletin Board: ADLS) today announced that the United States Food and Drug Administration (FDA) has granted Orphan Drug Designation to Restanza(TM) (cethromycin), its novel, once daily oral antibiotic, for the prophylactic treatment of plague and tularemia. Both tularemia and plague are classified by the Centers for Disease Control as Category A Bioterrorism Agents, which is the highest priority classification.
› Verified 5 days ago
Michele L Griffin, NP-C Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 1100 N College Ave, Fayetteville, AR 72703 Phone: 641-780-8696 | |
Durinda Pena, A.P.N. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 3232 N North Hills Blvd., Fayetteville, AR 72703 Phone: 479-587-1700 Fax: 479-587-1366 | |
Mrs. Diane H. Morrow, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 2630 E Citizens Dr Ste 13, Fayetteville, AR 72703 Phone: 479-571-6000 | |
Colby Hines, APRN Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 1100 N College Ave, Fayetteville, AR 72703 Phone: 479-443-4301 | |
Elizabeth Ann-grace Burns, APRN Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 3344 N Futrall Dr, Fayetteville, AR 72703 Phone: 479-521-8200 Fax: 479-582-7329 | |
Julia Marsh, FNP Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 180 E Sunbridge Dr, Fayetteville, AR 72703 Phone: 479-587-5805 Fax: 479-659-7930 | |
Mrs. Sue Ellen Schultz, A.P.N., F.N.P. Nurse Practitioner Medicare: Not Enrolled in Medicare Practice Location: 525 N Garland Ave, Fayetteville, AR 72701 Phone: 479-575-6479 Fax: 479-575-8793 |